MX358504B - Lagrimas artificiales y usos terapeuticos. - Google Patents

Lagrimas artificiales y usos terapeuticos.

Info

Publication number
MX358504B
MX358504B MX2014012100A MX2014012100A MX358504B MX 358504 B MX358504 B MX 358504B MX 2014012100 A MX2014012100 A MX 2014012100A MX 2014012100 A MX2014012100 A MX 2014012100A MX 358504 B MX358504 B MX 358504B
Authority
MX
Mexico
Prior art keywords
oil
artificial tears
therapeutic uses
dog
cat
Prior art date
Application number
MX2014012100A
Other languages
English (en)
Inventor
V Gore Anuradha
S Jordan Robert
Krock Kevin
Pujara Chetan
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42312750&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX358504(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of MX358504B publication Critical patent/MX358504B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/55—Linaceae (Flax family), e.g. Linum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención provee composiciones oftálmicas, v.gr., lágrimas artificiales, adecuadas para tratar síndrome de ojo seco en un humano u otro mamífero que padece el mismo, v.gr., un perro o gato, que comprende una mezcla de aceite de ricino con otro aceite, v.gr., un aceite alimenticio, v.gr., aceite de oliva, aceite de ajonjolí, aceite de maíz, etc.
MX2014012100A 2009-06-05 2010-06-03 Lagrimas artificiales y usos terapeuticos. MX358504B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18433909P 2009-06-05 2009-06-05
PCT/US2010/037153 WO2010141648A2 (en) 2009-06-05 2010-06-03 Artificial tears and therapeutic uses

Publications (1)

Publication Number Publication Date
MX358504B true MX358504B (es) 2018-08-21

Family

ID=42312750

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2014012100A MX358504B (es) 2009-06-05 2010-06-03 Lagrimas artificiales y usos terapeuticos.
MX2011013007A MX2011013007A (es) 2009-06-05 2010-06-03 Lagrimas artificiales y usos terapeuticos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2011013007A MX2011013007A (es) 2009-06-05 2010-06-03 Lagrimas artificiales y usos terapeuticos.

Country Status (24)

Country Link
US (6) US8496976B2 (es)
EP (1) EP2437762B1 (es)
KR (1) KR101778316B1 (es)
CN (2) CN102458430A (es)
AU (1) AU2010256652B2 (es)
BR (1) BRPI1011710B8 (es)
CA (1) CA2764802A1 (es)
DK (1) DK2437762T3 (es)
ES (1) ES2646338T3 (es)
HK (1) HK1214943A1 (es)
HR (1) HRP20171691T1 (es)
HU (1) HUE034213T2 (es)
IL (1) IL216800A (es)
LT (1) LT2437762T (es)
MX (2) MX358504B (es)
MY (1) MY172185A (es)
NO (1) NO2437762T3 (es)
NZ (1) NZ596932A (es)
PL (1) PL2437762T3 (es)
PT (1) PT2437762T (es)
RU (1) RU2589837C2 (es)
SI (1) SI2437762T1 (es)
WO (1) WO2010141648A2 (es)
ZA (1) ZA201108979B (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8569367B2 (en) 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
WO2010141648A2 (en) 2009-06-05 2010-12-09 Allergan, Inc. Artificial tears and therapeutic uses
US8957048B2 (en) * 2011-10-06 2015-02-17 Allergan, Inc. Compositions for the treatment of dry eye
IN2014CN04809A (es) * 2011-12-07 2015-09-18 Allergan Inc
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
US9278132B2 (en) * 2012-02-13 2016-03-08 Bausch & Lomb Incorporated Ophthalmic pharmaceutical compositions and methods of making and using same
US10085960B2 (en) 2012-03-30 2018-10-02 Brien Holden Vision Institute Methods and compositions for reducing ocular discomfort
US9289494B2 (en) 2013-11-20 2016-03-22 RestorTears, LLC Method of treating ocular disorders with compounds found in Harderian gland secretions
US9394355B2 (en) 2014-08-20 2016-07-19 Silk Technologies, Ltd. Fibroin-derived protein composition
EP3223794A1 (en) * 2014-11-25 2017-10-04 Allergan, Inc. Stabilized omega-3 ophthalmic compositions
WO2017066429A1 (en) 2015-10-14 2017-04-20 Paul Gavaris Ophthalmic treatment composition and vehicle for delivery of pharmaceutical substances or therapeutic agents
JP2019519596A (ja) 2016-04-08 2019-07-11 コーネル・ユニバーシティーCornell University シルク由来タンパク質を使用して創傷治癒を増進する方法
JOP20170147B1 (ar) * 2016-07-07 2021-08-17 Salvat Lab Sa تركيبة عينية تشتمل على زيت الخروع ودهون ثلاثية متوسطة السلسلة
KR102275012B1 (ko) 2016-08-12 2021-07-07 실크 테크놀로지스 리미티드 염증 치료용 실크 유래 단백질
WO2018035469A1 (en) * 2016-08-19 2018-02-22 Akrivista, LLC Methods of diagnosing and treating dry eye syndrome and compositions for treating a human eye
GB201618175D0 (en) * 2016-10-27 2016-12-14 Warneford Healthcare Ltd Pharmaceutical compositions
KR20200037230A (ko) * 2017-06-30 2020-04-08 제니비젼 인크. 모발 성장용 제제
JP7311160B2 (ja) 2017-08-18 2023-07-19 アクリビスタ エルエルシー ドライアイ症候群を診断及び処置する方法及びヒトの眼を処置するための組成物
CN112739337B (zh) 2018-07-27 2024-05-24 强生外科视力公司 用于治疗眼睛的组合物和方法
AU2019311849B2 (en) 2018-07-27 2023-06-08 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
CN112888450A (zh) 2018-07-27 2021-06-01 强生外科视力公司 用于治疗眼睛的组合物和方法
US11166997B2 (en) 2018-07-27 2021-11-09 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US10966948B2 (en) 2019-07-23 2021-04-06 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
WO2020021481A1 (en) 2018-07-27 2020-01-30 Johnson & Johnson Vision Care, Inc. Compositions and methods for treating the eye
US11197841B2 (en) 2019-07-23 2021-12-14 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US11110051B2 (en) 2018-08-30 2021-09-07 Johnson & Johnson Consumer Inc. Topical compositions comprising Pichia anomala and n-acetyl glucosamine
US11045416B2 (en) 2018-08-30 2021-06-29 Johnson & Johnson Consumer Inc. Topical compositions comprising Pichia anomala and retinol
KR20210009947A (ko) 2019-07-18 2021-01-27 윤영선 산소가 도입된 점안제, 및 그 제조방법
EP3824877A1 (en) 2019-11-19 2021-05-26 Johnson & Johnson Consumer Inc. Compositions and methods for treating the eye
US11969451B2 (en) 2019-11-19 2024-04-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
EP3824895A1 (en) 2019-11-19 2021-05-26 Johnson & Johnson Consumer Inc. Compositions and methods for treating the eye
US11969454B2 (en) 2019-11-19 2024-04-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
EP4059508A1 (en) 2021-03-19 2022-09-21 Johnson & Johnson Consumer Inc. Methods of using compositions comprising an iceland moss extract

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56104814A (en) * 1980-01-25 1981-08-20 Kunihiro Okanoe Preparation of eye drop
US4649047A (en) 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
US4839342A (en) 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin
DE3851152T2 (de) 1987-09-03 1995-01-26 Univ Georgia Cyclosporin-augenmittel.
FR2638089A1 (fr) * 1988-10-26 1990-04-27 Sandoz Sa Nouvelles compositions ophtalmiques a base d'une cyclosporine
US5474979A (en) 1994-05-17 1995-12-12 Allergan, Inc. Nonirritating emulsions for sensitive tissue
WO1997024129A1 (en) 1995-12-27 1997-07-10 Rohto Pharmaceutical Co., Ltd. Pharmaceutical composition containing trehalose
US5981607A (en) * 1998-01-20 1999-11-09 Allergan Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers
GB0012597D0 (en) 2000-05-25 2000-07-12 Astrazeneca Ab Formulation
US7027446B2 (en) 2001-07-18 2006-04-11 P-Cube Ltd. Method and apparatus for set intersection rule matching
JP4284491B2 (ja) 2002-07-16 2009-06-24 豊和工業株式会社 ピストン外形の加工データ生成装置
TWI335819B (en) * 2002-12-24 2011-01-11 Alcon Inc Use of oculosurface selective glucocorticoid in the treatment of dry eye
DK1599186T3 (da) * 2003-02-24 2013-07-08 Pharmaceutical Productions Inc System til administration af transmukalt lægemiddel
US20060251685A1 (en) * 2003-03-18 2006-11-09 Zhi-Jian Yu Stable ophthalmic oil-in-water emulsions with Omega-3 fatty acids for alleviating dry eye
US20040185068A1 (en) 2003-03-18 2004-09-23 Zhi-Jian Yu Self-emulsifying compositions, methods of use and preparation
CA2572344A1 (en) 2004-07-01 2006-01-19 Schepens Eye Research Compositions and methods for treating eye disorders and conditions
JPWO2006022291A1 (ja) * 2004-08-27 2008-05-08 千寿製薬株式会社 ドライアイ治療用点眼液
US8569367B2 (en) * 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
CN100562340C (zh) * 2005-06-17 2009-11-25 中国科学院上海药物研究所 一种微乳型人工泪液
US7202209B2 (en) 2005-07-13 2007-04-10 Allergan, Inc. Cyclosporin compositions
US7297679B2 (en) 2005-07-13 2007-11-20 Allergan, Inc. Cyclosporin compositions
US7288520B2 (en) 2005-07-13 2007-10-30 Allergan, Inc. Cyclosporin compositions
WO2008035246A2 (en) 2006-07-28 2008-03-27 Novagali Pharma Sa Compositions containing quaternary ammonium compounds
WO2008027341A2 (en) * 2006-08-30 2008-03-06 Merck & Co., Inc. Topical ophthalmic formulations
BRPI0808410A2 (pt) * 2007-02-28 2015-06-23 Aciex Therapeutics Inc Métodos e composições para normalizar secreções da glândula meibomiana
CN101554369B (zh) * 2008-05-12 2012-07-25 陈亚玲 一种外用复合油纳米乳喷雾剂和滴眼剂及其制备方法
UA36915U (uk) * 2008-05-28 2008-11-10 Львівський Національний Медичний Університет Ім. Данила Галицького Очні краплі для лікування запальних захворювань судинної оболонки та сухого кератокон'юнктивіту, які викликані аутоімунними процесами
IT1393419B1 (it) 2009-03-19 2012-04-20 Medivis S R L Composizioni oftalmiche a base di acidi grassi polinsaturi omega-3 e omega-6.
US9480645B2 (en) 2009-06-02 2016-11-01 Abbott Medical Optics Inc. Omega-3 oil containing ophthalmic emulsions
WO2010141648A2 (en) 2009-06-05 2010-12-09 Allergan, Inc. Artificial tears and therapeutic uses

Also Published As

Publication number Publication date
US20180264063A1 (en) 2018-09-20
RU2589837C2 (ru) 2016-07-10
PT2437762T (pt) 2017-11-14
CN102458430A (zh) 2012-05-16
WO2010141648A2 (en) 2010-12-09
NZ596932A (en) 2014-04-30
CN104906170A (zh) 2015-09-16
US8679554B2 (en) 2014-03-25
IL216800A (en) 2017-03-30
US20130295206A1 (en) 2013-11-07
US9821020B2 (en) 2017-11-21
HUE034213T2 (en) 2018-01-29
BRPI1011710B8 (pt) 2021-05-25
US8496976B2 (en) 2013-07-30
EP2437762B1 (en) 2017-08-09
US20140141106A1 (en) 2014-05-22
WO2010141648A3 (en) 2011-03-10
US11045515B2 (en) 2021-06-29
ES2646338T3 (es) 2017-12-13
HK1214943A1 (zh) 2016-08-12
EP2437762A2 (en) 2012-04-11
US20220008496A1 (en) 2022-01-13
IL216800A0 (en) 2012-02-29
BRPI1011710A8 (pt) 2019-11-05
US20240108677A1 (en) 2024-04-04
MX2011013007A (es) 2012-02-28
US20120201910A1 (en) 2012-08-09
KR101778316B1 (ko) 2017-09-13
NO2437762T3 (es) 2018-01-06
CA2764802A1 (en) 2010-12-09
HRP20171691T1 (hr) 2017-12-15
DK2437762T3 (da) 2017-11-20
PL2437762T3 (pl) 2018-01-31
SI2437762T1 (en) 2018-02-28
AU2010256652A1 (en) 2012-01-12
LT2437762T (lt) 2017-11-27
KR20120046151A (ko) 2012-05-09
AU2010256652B2 (en) 2015-11-26
BRPI1011710A2 (pt) 2016-03-22
ZA201108979B (en) 2012-08-29
RU2011151468A (ru) 2013-07-20
BRPI1011710B1 (pt) 2021-01-26
MY172185A (en) 2019-11-15

Similar Documents

Publication Publication Date Title
MY172185A (en) Artificial tears and therapeutic uses
PH12020550450A1 (en) Certain chemical entities, compositions and methods
MY169328A (en) Compositions for the treatment of dry eye
MY173616A (en) Compositions and methods for lowering triglycerides
WO2012064973A3 (en) Heterocyclic compounds and uses thereof
TN2010000122A1 (en) Compounds and compositions as modulators of gpr119 activity
WO2012024620A3 (en) Autotaxin inhibitors and uses thereof
CO6571886A2 (es) Antagonistas de pcsk9
WO2010083239A3 (en) Therapeutic modulation of vaginal epithelium boundary lubrication
AU2012253759A8 (en) Tricyclic sulfonamide compounds and methods of making and using same
EA201290498A1 (ru) Терапевтические полимерные наночастицы, включающие эпотилон, и способы их получения и применения
IN2012DN02469A (es)
WO2011019822A3 (en) Compositions and methods for implantation of processed adipose tissue and processed adipose tissue products
MY171920A (en) Prevention and treatment of ocular conditions
PL2262476T3 (pl) Dostarczanie leku do przedniego i tylnego odcinka oka z użyciem kropli do oczu
ATE456369T1 (de) Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
MX2011013060A (es) Formulaciones oftalmicas, metodos de preparacion y metodos para utilizarlas.
WO2009089635A9 (en) Treating neurodegenerative diseases with progranulin (pgrn)
IN2012DN00624A (es)
MX2012004078A (es) Compuestos y composiciones como moduladores de la actividad de gpr119.
WO2010121164A3 (en) 1,4-benzodiazepinone compounds and their use in treating cancer
BR112014000634A2 (pt) métodos para tratamento de incontinência associada com atividade sexual
UA108878C2 (ru) Ингибиторы протеинтирозинкиназной активности
UY33153A (es) Formulación tópica oftálmica de péptidos
WO2011011706A3 (en) Methods and compositions for treating or preventing autoimmune diseases using immunomodulatory agents